ExodusPoint Capital Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

ExodusPoint Capital Management’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,047	Closed	-$229K	–	2493
2022 Q2	$229K	Buy	+3,047	New	+$135K	﹤0.01%	1621
2021 Q2	–	Sell	-2,183	Closed	-$206K	–	3011
2021 Q1	$206K	Sell	2,183 -1,919	-47%	-$228K	﹤0.01%	1861
2020 Q4	$500K	Buy	4,102 +1,148	+39%	+$126K	﹤0.01%	1253
2020 Q3	$258K	Buy	+2,954	New	+$206K	0.01%	1356

ExodusPoint Capital Management's TPTX Position: Q3 2022 in Review

ExodusPoint Capital Management sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 3,047 shares — an estimated $229K sold.

ExodusPoint Capital Management first reported a position in TPTX in Q3 2020 and held it in 4 quarters. The position peaked at $500K in Q4 2020. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

ExodusPoint Capital Management reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
ExodusPoint Capital Management sold 3,047 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $229K.
ExodusPoint Capital Management first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
ExodusPoint Capital Management's Turning Point Therapeutics, Inc. Common Stock position peaked at $500K in Q4 2020.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on ExodusPoint Capital Management's 13F filing for Q3 2022, filed 10 Nov 2022.